Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 81-114, September 2002

Ion channels in pulmonary arterial hypertension☆☆

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California School of Medicine, San Diego, CA.

Abstract 

Pulmonary arterial hypertension (PAH) is a hemodynamic abnormality that ultimately results in mortality due to right heart failure. Although the clinical manifestations of primary and secondary PAH are diverse, medial hypertrophy and arterial vasoconstriction are key components in the vascular remodeling leading to PAH. Abnormalities in the homeostasis of intracellular Ca2+, transmembrane flux of ions, and membrane potential may play significant roles in the processes leading to pulmonary vascular remodeling. Decreased activity of K+ channels causes membrane depolarization, leading to Ca2+ influx. The elevated cytoplasmic Ca2+ is a major trigger for pulmonary vasoconstriction and an important stimulus for vascular smooth muscle proliferation. Dysfunctional K+ channels have also been linked to inhibition of apoptosis and contribute further to the medial hypertrophy. This review focuses on the relative role of K+ and Ca2+ ions and channels in human pulmonary artery smooth muscle cells in the development of PAH. Copyright 2002, Elsevier Science (USA). All rights reserved.

Progress in Cardiovascular Diseases, Vol. 45, No. 2, (September/October) 2002: pp 81-114

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from the National Institutes of Health (HL 54043, HL 64945, HL 66012, and HL 69758). and the American Heart Association.

☆☆ Address reprint rquests to Jason X.-J. Yuan, MD, PhD, Division of Pulmonary and Critical Care Medicine, UCSD Medical Center, 200 W. Arbor Dr, San Diego, CA 92103-8382.

PII: S0033-0620(02)70001-7

doi:10.1053/pcad.2002.127491

Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 81-114, September 2002